• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

试验中繁琐的研究程序:为何少即是多。

Burdensome Research Procedures in Trials: Why Less Is More.

作者信息

Kimmelman Jonathan, Resnik David B, Peppercorn Jeffrey, Ratain Mark J

机构信息

Studies of Translation, Ethics and Medicine (STREAM), Biomedical Ethics Unit, Social Studies of Medicine, McGill University, Montréal, Canada.

National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.

出版信息

J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djw315.

DOI:10.1093/jnci/djw315
PMID:28376159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5756064/
Abstract

A large volume of trials involve invasive, nontherapeutic research procedures, like organ biopsy or sham surgeries, that can pose risks comparable with the experimental treatment itself but that have no direct benefit for volunteers. Though such procedures can enhance the value of clinical investigations, recent studies suggest that many studies involving invasive, nontherapeutic research procedures are not well planned and reported; some studies suggest that their results are often not utilized in the planning of new investigations. This commentary offers recommendations for how investigators, sponsors, and ethics committees might improve evaluation and implementation of studies involving invasive nontherapeutic procedures. We conclude by urging more demanding scientific standards for the rationale, design, and reporting of burdensome, nontherapeutic research procedures-particularly where they involve risk of serious complications.

摘要

大量试验涉及侵入性、非治疗性研究程序,如器官活检或假手术,这些程序可能带来与实验性治疗本身相当的风险,但对志愿者没有直接益处。尽管此类程序可提高临床研究的价值,但最近的研究表明,许多涉及侵入性、非治疗性研究程序的研究规划和报告并不完善;一些研究表明,其结果往往未被用于新研究的规划中。本评论针对研究者、资助者和伦理委员会如何改进对涉及侵入性非治疗性程序研究的评估和实施提出了建议。我们最后敦促对繁重的非治疗性研究程序的基本原理、设计和报告采用更严格的科学标准,尤其是在这些程序涉及严重并发症风险的情况下。

相似文献

1
Burdensome Research Procedures in Trials: Why Less Is More.试验中繁琐的研究程序:为何少即是多。
J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djw315.
2
Survey of users of TOPS, an internet-based system to prevent healthy subjects from over-volunteering for clinical trials.基于互联网的 TOPS 系统旨在防止健康受试者过度自愿参加临床试验,对其用户的调查。
Eur J Clin Pharmacol. 2013 Oct;69(10):1757-60. doi: 10.1007/s00228-013-1534-4. Epub 2013 Jun 7.
3
Clinical research with healthy volunteers: an ethical framework.健康志愿者的临床研究:一个伦理框架。
J Investig Med. 2003 Feb;51 Suppl 1:S2-5.
4
Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit.量化联邦最低风险标准:对无直接受益前景的儿科研究的影响。
JAMA. 2005 Aug 17;294(7):826-32. doi: 10.1001/jama.294.7.826.
5
Pediatric research and the federal minimal risk standard.儿科研究与联邦最低风险标准。
JAMA. 2006 Feb 15;295(7):759; author reply 759-60. doi: 10.1001/jama.295.7.759-a.
6
Sham neurosurgical procedures: the patients' perspective.假神经外科手术:患者视角
Lancet Neurol. 2012 Dec;11(12):1022. doi: 10.1016/S1474-4422(12)70277-6.
7
Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations.神经退行性疾病临床试验中的假神经外科手术:科学和伦理考虑。
Lancet Neurol. 2012 Jul;11(7):643-50. doi: 10.1016/S1474-4422(12)70064-9.
8
Sham surgery and genuine standards of care: can the two be reconciled?假手术与真正的医疗标准:二者能否协调一致?
Am J Bioeth. 2003 Autumn;3(4):61-4. doi: 10.1162/152651603322614652.
9
International codes of research ethics: current controversies and the future.国际研究伦理准则:当前争议与未来发展
Indiana Law Rev. 2002;35(2):557-67.
10
Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products.欧洲药品管理局关于确定和降低研究用药品首次人体试验和早期临床试验风险策略的指南评注
Br J Clin Pharmacol. 2018 Jul;84(7):1401-1409. doi: 10.1111/bcp.13550. Epub 2018 May 30.

引用本文的文献

1
Decision making for invasive and non-invasive optional procedures within an acute HIV research cohort in Bangkok.曼谷急性HIV研究队列中侵入性和非侵入性可选程序的决策制定
Contemp Clin Trials Commun. 2022 Dec 23;31:101054. doi: 10.1016/j.conctc.2022.101054. eCollection 2023 Feb.
2
Understanding factors contributing to participant satisfaction in stroke walking recovery clinical trials.了解影响中风步行恢复临床试验中参与者满意度的因素。
Contemp Clin Trials Commun. 2022 Jun 11;28:100945. doi: 10.1016/j.conctc.2022.100945. eCollection 2022 Aug.
3
Patient perspectives on window of opportunity clinical trials in early-stage breast cancer.早期乳腺癌患者对机会窗临床试验的看法。
Breast Cancer Res Treat. 2022 Jul;194(1):171-178. doi: 10.1007/s10549-022-06611-6. Epub 2022 May 11.
4
Practical consideration for successful sequential tumor biopsies in first-in-human trials.在首次人体试验中成功进行连续肿瘤活检的实用考虑因素。
Invest New Drugs. 2022 Aug;40(4):841-849. doi: 10.1007/s10637-022-01236-4. Epub 2022 Apr 11.
5
Therapeutic Misconception about Research Procedures: Does a Simple Information Chart Improve Understanding?研究程序的治疗性误解:简单的信息图表是否能提高理解?
Ethics Hum Res. 2022 Mar;44(2):18-25. doi: 10.1002/eahr.500120.
6
Implications of Research Biopsies in Clinical Trials.临床试验中研究活检的意义。
Oncologist. 2021 Dec;26(12):994-996. doi: 10.1002/onco.13948. Epub 2021 Aug 31.
7
Details of risk-benefit communication in informed consent documents for phase I/II trials.知情同意书在 I/II 期临床试验中的风险效益沟通细节。
Clin Trials. 2021 Feb;18(1):71-80. doi: 10.1177/1740774520971770. Epub 2020 Nov 24.
8
Risk Assessment of Medical Study Procedures in the Documents Submitted to a Research Ethics Committee.向研究伦理委员会提交的医学研究文件中的研究程序风险评估。
J Empir Res Hum Res Ethics. 2020 Dec;15(5):396-406. doi: 10.1177/1556264620903563. Epub 2020 Feb 8.
9
The research burden of randomized controlled trial participation: a systematic thematic synthesis of qualitative evidence.随机对照试验参与的研究负担:定性证据的系统主题综合分析。
BMC Med. 2020 Jan 20;18(1):6. doi: 10.1186/s12916-019-1476-5.
10
Umbrella and basket trials in oncology: ethical challenges.肿瘤学中的伞形试验和篮子试验:伦理挑战。
BMC Med Ethics. 2019 Aug 23;20(1):58. doi: 10.1186/s12910-019-0395-5.

本文引用的文献

1
Trends in the characteristics, dose-limiting toxicities and efficacy of phase I oncology trials: The Cancer Research UK experience.英国癌症研究的经验:I期肿瘤学试验的特征、剂量限制性毒性及疗效趋势
Eur J Cancer. 2016 Oct;66:9-16. doi: 10.1016/j.ejca.2016.07.004. Epub 2016 Aug 8.
2
Analysis of Impact of Post-Treatment Biopsies in Phase I Clinical Trials.I期临床试验中治疗后活检的影响分析
J Clin Oncol. 2016 Feb 1;34(4):369-74. doi: 10.1200/JCO.2015.63.6126. Epub 2015 Dec 14.
3
Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells.PACE:间歇性跛行患者注射 ALDH 明亮细胞的原理和设计。
Am Heart J. 2014 Nov;168(5):667-73. doi: 10.1016/j.ahj.2014.07.021. Epub 2014 Jul 30.
4
Patients' perceptions of research biopsies in phase I oncology trials.患者对肿瘤学I期试验中研究性活检的看法。
Oncology. 2015;88(2):95-102. doi: 10.1159/000368161. Epub 2014 Oct 14.
5
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.两项评估 bapineuzumab 治疗轻度至中度阿尔茨海默病的 3 期临床试验。
N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.
6
Reporting practices of pharmacodynamic studies involving invasive research procedures in cancer trials.涉及侵袭性研究程序的癌症试验中药效学研究的报告实践。
Br J Cancer. 2013 Aug 20;109(4):897-908. doi: 10.1038/bjc.2013.417. Epub 2013 Jul 25.
7
Attitudes of patients with metastatic breast cancer toward research biopsies.转移性乳腺癌患者对研究性活检的态度。
Ann Oncol. 2013 Jul;24(7):1853-1859. doi: 10.1093/annonc/mdt067. Epub 2013 Mar 13.
8
Use of research biopsies in clinical trials: are risks and benefits adequately discussed?临床研究中使用研究活检:风险和获益是否得到充分讨论?
J Clin Oncol. 2013 Jan 1;31(1):17-22. doi: 10.1200/JCO.2012.43.1718. Epub 2012 Nov 5.
9
Publication and reporting conduct for pharmacodynamic analyses of tumor tissue in early-phase oncology trials.肿瘤组织早期肿瘤学试验药效学分析的发表和报告行为。
Clin Cancer Res. 2012 Dec 1;18(23):6478-84. doi: 10.1158/1078-0432.CCR-12-1384. Epub 2012 Aug 21.
10
Towards the incorporation of lumbar puncture into clinical trials for multiple sclerosis.关于将腰椎穿刺纳入多发性硬化症临床试验的探讨。
Mult Scler. 2012 Oct;18(10):1509-11. doi: 10.1177/1352458512438117. Epub 2012 Feb 1.